 Zaks Small Cap Research has provided its feedback from a key opinion leader virtual event hosted by Tiziana Life Sciences Ltd. The set-piece was organized after the publication of encouraging data from a trial of Tizianas lead drug, which was used to treat a single patient with secondary progressive multiple sclerosis, an advanced form of the disease. 